For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Therasense, Inc.

USPTO Granted Patents = 53

% Expired Patents = 3.8

CIPO Patents = 1

EPO Patents = 1

Trademarks = 3

Forward Citations = 46,901

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Adam Heller (37 out of 276 patents)

James L Say (13 out of 121 patents)

Fei Mao (11 out of 136 patents)

4. Ephraim Heller (11 out of 126 patents)

5. Mark S Vreeke (11 out of 92 patents)

6. Benjamin J Feldman (11 out of 250 patents)

7. Fredric C Colman (10 out of 114 patents)

8. Joseph A Vivolo (9 out of 57 patents)

9. Phillip John Plante (8 out of 75 patents)

10. Michael F Tomasco (8 out of 97 patents)

11. Jeffery Van Funderburk (8 out of 95 patents)

12. Rajesh Krishnan (7 out of 44 patents)

13. Behrad Aria (6 out of 78 patents)

14. Yoram Gal (6 out of 75 patents)

15. Keith A Friedman (4 out of 51 patents)

Core Competencies:

RF Tag

Transition Metal Complexes

Glucose Monitoring

Electrochemical Sensors

Biosensor Membranes

Lancing Device

Subcutaneous Electrodes

Analyte Monitoring

Biological Fuel Cell

Mass Transport Limited Sensors

Potentiometric Sensors

Redox Polymers

53 patents: Sort by Forward Citations

1. 7545272 - RF tag on test strips, test strip vials and boxes (2009-06-09),

2. 7090756 - Transition metal complexes with bidentate ligand having an imidazole ring (2006-08-15),

3. 7074308 - Transition metal complexes with (pyridyl)imidazole ligands (2006-07-11),

4. 7058437 - Methods of determining concentration of glucose (2006-06-06),

5. 7052591 - Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking (2006-05-30),

6. 7041468 - Blood glucose tracking apparatus and methods (2006-05-09),

7. 7005273 - Method for the determination of glycated hemoglobin (2006-02-28),

8. 6990366 - Analyte monitoring device and methods of use (2006-01-24),

9. 6975893 - Mass transport limited in vivo analyte sensor (2005-12-13),

10. 6973706 - Method of making a transcutaneous electrochemical sensor (2005-12-13),

11. 6942518 - Small volume in vitro analyte sensor and methods (2005-09-13),

12. 6932894 - Biosensor membranes composed of polymers containing heterocyclic nitrogens (2005-08-23),

13. 6916159 - Device and method employing shape memory alloy (2005-07-12),

14. 6893545 - Biosensor (2005-05-17),

15. 6881551 - Subcutaneous glucose electrode (2005-04-19),

TheraSense, Inc. is a leading medical technology company that specializes in the development and manufacture of glucose monitoring systems. They provide innovative and reliable products for people with diabetes to monitor their blood sugar levels easily and accurately. With a focus on improving the quality of life for diabetes patients, TheraSense, Inc. continues to drive advancements in glucose monitoring technology. For more information about their products and services, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

53 Patents

#12 in Alameda, CA

#1,563 in California

#6,656 in US

#13,296 in the World

Alameda, CA, United States of America

Therasense, Inc.

Forward Citations = 46,901

60 inventors:

Adam Heller (37 out of 276 patents)

James L Say (13 out of 121 patents)

Fei Mao (11 out of 136 patents)

4. Ephraim Heller (11 out of 126 patents)

5. Mark S Vreeke (11 out of 92 patents)

Please report any incorrect information to [email protected]

Loading…